CannaVest Corp. Wins Michigan Medical Cannabis Cup for Highest Cannabidiol (CBD) Concentrate

LAS VEGAS, July 30, 2014 /PRNewswire/ -- CannaVest Corp. (OTCBB:CANV), a leading manufacturer and distributor of hemp and Cannabidiol (CBD) based products, was awarded first place in the CBD concentrate category at the 2014 Michigan Medical Cannabis Cup, in Clio, Michigan on Sunday, July 27, 2014. CannaVest's proprietary pharmaceutical grade CBD concentrate, CBD Simple™, consistently achieves the highest CBD concentration in the industry, and has won this category in the High Times Cannabis Cup a record four times. Additionally, CannaVest has been awarded first place in the 2013 Michigan Green Cup, also in the CBD Concentrate category.

PlusCBD™ Oil, a consumer grade version of CBD-rich hemp oil, is exclusively manufactured by CannaVest Laboratories, a division of CannaVest Corp. in San Diego, California, under the direction of Dr. Joshua Hartsel, its lead research scientist.  Dr. Hartsel explains how the Company has been able to achieve its high CBD concentrations. "We spent the past few years improving on specialized techniques to purify CBD-rich hemp oil and are currently working on our first patent submissions in this area. We have been able to achieve the highest CBD purity levels using our proprietary refining methods. The lengthy orthogonal purification techniques are complex and have required years of research to attain the industry's highest CBD concentrate levels from raw CO2 oil."

CBD is a promising non-psychoactive nutraceutical product isolated from industrial hemp, and has been recognized for its pluripotent benefits on human health. PubMed, the online database of the US National Library of Medicine for the National Institutes of Health, states that, Cannabidiol (CBD) is a phytocannabinoid with therapeutic properties for numerous disorders, and is presently under preclinical research in trials for some specific diseases. The website notation on CBD cites that, within the endocannabinoid system, CBD has been shown to have an inhibitory effect on the inactivation of endocannabinoids, thereby enhancing the action of these endogenous molecules on cannabinoid receptors, which is also noted in certain pathological conditions.

CannaVest Laboratories was established to facilitate cutting edge research on cannabidiol (CBD), and is equipped with state of the art high-performance equipment and distillation tools to produce award winning CBD Simple™, and PlusCBD™ Oil. Additionally, CannaVest is pleased to report the distinction of adding Dr. Alexandros Makriyannis to lead its Scientific Advisory Board. Dr. Makriyannis is credited with early discoveries of the human endocannabinoid system, which has implications for CBD research and use. Dr. Makriyannis is also the founder of the Boston-based drug discovery company, MAKScientific, which specializes in the development and commercialization of novel therapeutics that modulate the endocannabinoid system, with advanced preclinical drug candidates. Dr. Hartsel reports that CannaVest Laboratories will collaborate directly with Dr. Makriyannis' Boston-based lab and MAKScientific.

Dr. Hartsel, CannaVest Laboratories lead research scientist concludes, "as we continue to learn more about CBD and its benefits, I believe this exciting molecule will be embraced as one of the most important compounds of the century."

About CannaVest Corp.

CannaVest Corp. (OTCBB:CANV), located in Las Vegas, Nevada, focuses on the procurement and wholesale of the hemp plant extract cannabidiol (CBD), and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. CannaVest resells raw industrial hemp product to third parties, acquired through supply relationships in Europe. Additional information is available from OTCMarkets.com or by visiting www.cannavest.com.

CannaVest Corp.'s subsidiaries include CannaVest Laboratories (www.CannaVestLabs.com) that facilitates cutting edge research and develops nutraceutical and food products, containing cannabidiol (CBD) oil; and is the developer and manufacturer of CannaVest's own award winning CBD Simple™.  US Hemp Oil, LLC. (www.USHempOil.com) provides seed procurement, cultivation, processing, and production consultation; and equipment to support U.S. farmers, researchers and businesses to cultivate and process industrial hemp in the US. USHO plans to build seed-processing mills and bring hemp based products to market.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of CannaVest Corp. to be materially different from the statements made herein.

LEGAL DISCLOSURE
CannaVest Corp. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets.

Corporate Contact:
CannaVest Corp.
2688 S. Rainbow Blvd., Ste. B
Las Vegas, NV 89146
Office: 866-290-2157

Logo - http://photos.prnewswire.com/prnh/20140403/LA98016LOGO

SOURCE CannaVest Corp.